Company announcement no.18/2010 October 1, 2010 Chr. Hansen Holding A/S plans to release its financial results and to hold its annual general meeting in 2010/2011 on the following dates: 2010 30 November Annual General Meeting Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday 18 October at 16.00 CET. 2011 12 January Interim Report (Q1 2010/11) 6 April Interim Report (Q2 2010/11) 6 July Interim Report (Q3 2010/11) 3 November Annual Report 2010/11 29 November Annual General Meeting Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday 17 October at 16.00 CET. For further information, please contact: Henning Jakobsen, CFO Tel: +45 4574 7621 Anders Mohr Christensen, Investor Relations Tel: +45 4574 7618 About Chr. Hansen Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. Revenue in FY 2008/09 was EUR 511 million. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Colors & Blends. There are more than 2,200 dedicated employees in over 30 countries. For further information, please visit www.chr-hansen.com.